{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T08:30:23Z","timestamp":1770885023785,"version":"3.50.1"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.vaccine.2007.04.042","type":"journal-article","created":{"date-parts":[[2007,5,12]],"date-time":"2007-05-12T11:13:19Z","timestamp":1178968399000},"page":"A58-A62","source":"Crossref","is-referenced-by-count":6,"special_numbering":"S1","title":["A new approach to the definition of seroconversion following vaccination in a population with high background antibody concentrations"],"prefix":"10.1016","volume":"25","author":[{"given":"Daniel","family":"Chandramohan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Greenwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.04.042_bib1","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","article-title":"Human immunity to the meningococcus. The role of humoral antibodies","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2007.04.042_bib2","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.4049\/jimmunol.130.6.2882","article-title":"IgA blocks IgM and IgG-initiated immune lysis by separate molecular mechanisms","volume":"130","author":"Griffiss","year":"1983","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2007.04.042_bib3","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/infdis\/174.6.1360","article-title":"Reactogenicity and immunogenicity of conjugate meningococcal serogroup A and C vaccines in UK infants","volume":"174","author":"Fairly","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.04.042_bib4","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1128\/IAI.69.4.2378-2382.2001","article-title":"Evaluation of De-O-acetylated meningococcal C polysaccharide-tetanus toxoid conjugate vaccine in infancy: reactogenicity, immunogenicity, immunologic priming, and bactericidal activity against O-acetylated and De-O-acetylated serogroup C strains","volume":"69","author":"Richamond","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.04.042_bib5","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1086\/345763","article-title":"Safety, reactogenicity, and immunogenicity of a tetravalent meningococcal polysaccharide-diphtheria toxoid conjugate vaccine given to healthy adults","volume":"186","author":"Campbell","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.04.042_bib6","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1128\/IAI.42.2.599-604.1983","article-title":"Reactivity and immunogenicity of bivalent (AC) and tetravalent (ACW135Y) meningococcal vaccines containing O-acetyl-negative or O-acetyl-positive group C polysaccharide","volume":"42","author":"Vodopija","year":"1983","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.04.042_bib7","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/00006454-200002000-00013","article-title":"Safety and immunogenicity of three doses of a Neisseria meningitidis A+C diphtheria conjugate vaccine in infants from Niger","volume":"19","author":"Campagne","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2007.04.042_bib8","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/S0264-410X(01)00299-7","article-title":"Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story","volume":"20","author":"Miller","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.04.042_bib9","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1128\/IAI.69.3.1568-1573.2001","article-title":"Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection","volume":"69","author":"Borrow","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.04.042_bib10","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1128\/CDLI.10.5.780-786.2003","article-title":"Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England","volume":"10","author":"Andrews","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2007.04.042_bib11","first-page":"317","article-title":"Immunogenicity and side effects of a new tetravalent meningococcal polysaccharide vaccine","volume":"61","author":"Ambrosch","year":"1983","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2007.04.042_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2007.04.047","article-title":"An evaluation of the immunogenicity and safety of a new trivalent meningococcal polysaccharide vaccine","author":"Chandramohan","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.04.042_bib13","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/infdis\/142.6.861","article-title":"Serum antibodies to capsular polysaccharide vaccine group A Neisseria meningitidis followed for 3 years in infants and children","volume":"142","author":"Kayhty","year":"1980","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.04.042_bib14","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/infdis\/137.2.112","article-title":"Carriage of Neisseria meningitidis and Neisseria lactamica in infants and children","volume":"137","author":"Gold","year":"1978","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07004677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07004677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T20:16:50Z","timestamp":1683836210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07004677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":14,"alternative-id":["S0264410X07004677"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.04.042","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}